{"status": "OK", "response": {"docs": [{"type_of_material": "Summary", "blog": [], "news_desk": "Metropolitan Desk", "lead_paragraph": "INTERNATIONAL A3-12 U.S. Agencies Divided Over Missile Defense Senior officials at the Pentagon and the State Department said the two agencies were sharply divided over whether and how to move ahead with construction of a limited national missile defense. The dispute is rooted in legal interpretations of when the United States would have to give formal notice to Russia that it was violating the Anti-Ballistic Missile Treaty of 1972, most likely involving construction of radar sites. A1", "headline": {"main": "NEWS SUMMARY"}, "abstract": null, "print_page": "2", "word_count": 1200, "_id": "4fd2370d8eb7c8105d7c95f2", "snippet": "INTERNATIONAL   A3-12    U.S. Agencies Divided Over Missile Defense  Senior officials at the Pentagon and the State Department said the two agencies were sharply divided over whether and how to move ahead with construction of a limited national...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2000/08/30/nyregion/news-summary-904708.html", "multimedia": [], "subsection_name": null, "keywords": [], "byline": null, "document_type": "article", "pub_date": "2000-08-30T00:00:00Z", "section_name": "New York and Region"}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "Vice President Al Gore today escalated his attacks against the pharmaceutical industry, criticizing the makers of two prescription drugs by name, calling for greater competition and promoting his plan for a Medicare drug benefit. The drug industry has long been one of Mr. Gore's corporate bogeymen, along with oil, tobacco and insurance. But in today's speech to a forum of elderly people at Florida State University, Mr. Gore expanded his criticism, saying he would veto any legislation extending monopoly patents for prescription drugs. ''You elect me president and I'll veto every one of those bills,'' he said.", "headline": {"main": "Gore, in Attack on Drug Industry, Focuses on 2 Medicines", "kicker": "THE 2000 CAMPAIGN: THE VICE PRESIDENT"}, "abstract": "Vice Pres Al Gore escalates his attacks on pharmaceutical industry, criticizing makers of two prescription drugs by name, calling for greater competition and promoting his plan for a Medicare drug benefit; singles out Claritin, antihistamine made by Schering-Plough Corp, and arthritis drug Lodine, made by Wyeth-Ayerst Laboratories; photo (M)", "print_page": "19", "word_count": 865, "_id": "4fd236c78eb7c8105d7c922c", "snippet": "Vice President Al Gore today escalated his attacks against the pharmaceutical industry, criticizing the makers of two prescription drugs by name, calling for greater competition and promoting his plan for a Medicare drug benefit.     The drug...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2000/08/29/us/2000-campaign-vice-president-gore-attack-drug-industry-focuses-2-medicines.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "GORE, AL"}, {"name": "organizations", "value": "SCHERING-PLOUGH CORP"}, {"name": "organizations", "value": "WYETH-AYERST LABORATORIES"}, {"name": "subject", "value": "LODINE (DRUG)"}, {"name": "subject", "value": "CLARITIN (DRUG)"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "ELECTION ISSUES"}, {"name": "subject", "value": "PRICES (FARES, FEES AND RATES)"}, {"name": "subject", "value": "PRESIDENTIAL ELECTION OF 2000"}, {"name": "subject", "value": "ARTHRITIS AND RHEUMATISM"}, {"name": "subject", "value": "AGED"}, {"name": "subject", "value": "MEDICARE"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "ALLERGIES"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Kevin", "lastname": "SACK"}], "original": "By KEVIN SACK"}, "document_type": "article", "pub_date": "2000-08-29T00:00:00Z", "section_name": "Health; U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "Health & Fitness", "lead_paragraph": "Citing ''rare but serious risks'' from Lotronex, a drug prescribed for women with irritable bowel syndrome, the Food and Drug Administration has ordered that a warning pamphlet be attached to each bottle of pills to alert consumers to early signs of dangerous side effects. The order on Thursday, the first time that such a pamphlet has been required for any drug, came about because serious side effects have been reported in 15 patients since Lotronex was approved in February. It is used to treat women with chronic diarrhea resulting from the bowel syndrome.", "headline": {"main": "Side Effects Of a Drug Spur Alert To Users"}, "abstract": "Food and Drug Administration orders that warning pamphlets be attached to bottles of Lotronex, drug prescribed to treat chronic diarrhea in women with irritable bowel syndrome, to alert consumers to early signs of rare but serious side effects, including severe constipation and ischemic colitis; says benefits of drug outweigh risks; Public Citizen's Health Research Group director, Sidney M Wolfe, says drug should be taken off market because syndrome is not life-threatening, while side effects could be (M)", "print_page": "7", "word_count": 759, "_id": "4fd2087e8eb7c8105d773876", "snippet": "Citing ''rare but serious risks'' from Lotronex, a drug prescribed for women with irritable bowel syndrome, the Food and Drug Administration has ordered that a warning pamphlet be attached to each bottle of pills to alert consumers to early signs of...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2000/08/29/health/side-effects-of-a-drug-spur-alert-to-users.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "WOLFE, SIDNEY M"}, {"name": "organizations", "value": "PUBLIC CITIZEN'S HEALTH RESEARCH GROUP"}, {"name": "organizations", "value": "FOOD AND DRUG ADMINISTRATION"}, {"name": "subject", "value": "DIARRHEA"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "LABELING AND LABELS"}, {"name": "subject", "value": "LOTRONEX (DRUG)"}, {"name": "subject", "value": "WOMEN"}, {"name": "subject", "value": "IRRITABLE BOWEL SYNDROME"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Denise", "lastname": "GRADY"}], "original": "By DENISE GRADY"}, "document_type": "article", "pub_date": "2000-08-29T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Health & Fitness", "lead_paragraph": "Dick Richards of Anderson, Calif., goes for his physical every year, and his doctor jots down his height and weight. The doctor does not react to the fact that each year Mr. Richards is shorter. Maybe he never looks back over Mr. Richards' file to compare, or if he does notice the change, he does not think twice about it.", "headline": {"main": "The 'Women's Disease' That Also Strikes Men"}, "abstract": "Strong link between osteoporosis and women causes many doctors to overlook disease in men, who account for only 20 percent of 10 million Americans with osteoporosis or low bone mass; lack of awareness among doctors and men has led to delays in diagnosis and treatment; disease manifests itself later in life in men than women, with fractures starting to increase around age 60 in women and between 65 and 70 in men; doctors treat men with therapies that have proven effective in women, but not yet in men; table of secondary causes of disease in men; photos (M)", "print_page": "7", "word_count": 1643, "_id": "4fd236c78eb7c8105d7c9226", "snippet": "Dick Richards of Anderson, Calif., goes for his physical every year, and his doctor jots down his height and weight. The doctor does not react to the fact that each year Mr. Richards is shorter.    Maybe he never looks back over Mr. Richards' file to...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2000/08/29/health/the-women-s-disease-that-also-strikes-men.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "MEN"}, {"name": "subject", "value": "BONES"}, {"name": "subject", "value": "WOMEN"}, {"name": "subject", "value": "OSTEOPOROSIS"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Laurie", "lastname": "TARKAN"}], "original": "By LAURIE TARKAN"}, "document_type": "article", "pub_date": "2000-08-29T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "The second most popular kind of drug used to lower high blood pressure is less effective than other drugs in preventing heart attacks and heart failure, according to a study being reported today. The use of such drugs, known as calcium channel blockers, is leading to nearly 85,000 avoidable heart attacks and cases of heart failure each year worldwide, with half the cases in the United States, the study's authors are reporting at a meeting in Amsterdam of the European Cardiology Society. The findings seem likely to extend a long and bitter debate over the safety and effectiveness of calcium channel blockers to treat high blood pressure, which is also called hypertension.", "headline": {"main": "Use of Some Hypertension Drugs Questioned"}, "abstract": "Stidy by European Cardiology Society finds calcium channel blockers, second most popular kind of drug used to lower high blood pressure, is less effective than other drugs in preventing heart attacks and heart failure; says use of such drugs is leading to nearly 85,000 avoidable heart attacks and cases of heart failure each year worldwide, with half cases in US; findings detailed (M)", "print_page": "17", "word_count": 1243, "_id": "4fd22b3e8eb7c8105d7b6c9e", "snippet": "The second most popular kind of drug used to lower high blood pressure is less effective than other drugs in preventing heart attacks and heart failure, according to a study being reported today.    The use of such drugs, known as calcium channel...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2000/08/29/us/use-of-some-hypertension-drugs-questioned.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "EUROPEAN CARDIOLOGY SOCIETY"}, {"name": "subject", "value": "HEART"}, {"name": "subject", "value": "CALCIUM CHANNEL BLOCKER (DRUG)"}, {"name": "subject", "value": "BLOOD PRESSURE"}], "byline": {"person": [{"firstname": "Lawrence", "middlename": "K.", "lastname": "ALTMAN", "rank": 1, "role": "reported", "organization": ""}], "original": "By LAWRENCE K. ALTMAN"}, "document_type": "article", "pub_date": "2000-08-29T00:00:00Z", "section_name": "Health; U.S."}], "meta": {"hits": 5, "offset": 0, "time": 37}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}